Last $47.27 USD
Change Today -1.81 / -3.69%
Volume 609.6K
ABCO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

advisory board co/the (ABCO) Snapshot

Open
$49.00
Previous Close
$49.08
Day High
$49.00
Day Low
$47.05
52 Week High
03/21/14 - $70.14
52 Week Low
12/10/14 - $37.47
Market Cap
1.7B
Average Volume 10 Days
718.5K
EPS TTM
$0.33
Shares Outstanding
36.0M
EX-Date
--
P/E TM
141.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for ADVISORY BOARD CO/THE (ABCO)

advisory board co/the (ABCO) Related Businessweek News

No Related Businessweek News Found

advisory board co/the (ABCO) Details

The Advisory Board Company provides best practices research and analysis, business intelligence and performance technology software, and consulting and management services to the health care and education industries in the United States and internationally. Its best practices research and insight programs include access to studies, executive education, proprietary databases and online services, executive briefings, and other services. The company’s best practices research and insight memberships serve as the foundation of intellectual property across various programs and are focused on understanding industry dynamics, identifying best-demonstrated management practices, critiquing widely-followed but ineffective practices, and analyzing emerging trends within the health care and education industries. Its performance technologies software tools allow members to increase revenue, reduce cost, and enhance quality by pairing their own operational data with the best practices insights from its research; and consulting and management services provides strategic and operational support to member institutions to achieve key clinical quality and financial performance goals, as well as assist member institutions’ efforts to adopt and implement best practices. The company offers its services through discrete programs to approximately 4,500 organizations, including hospitals, health systems, pharmaceutical and biotechnology companies, health care insurers, medical device companies, colleges, universities, and other health care focused organizations and educational institutions. The Advisory Board Company was founded in 1979 and is headquartered in Washington, District of Columbia.

2,800 Employees
Last Reported Date: 05/30/14
Founded in 1979

advisory board co/the (ABCO) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $641.7K
President and Director
Total Annual Compensation: $470.8K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $325.0K
President of Performance Technologies and Con...
Total Annual Compensation: $425.0K
Executive Vice President
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2014.

advisory board co/the (ABCO) Key Developments

Royall & Company, Inc., The Advisory Board Company - M&A Call

Royall & Company, Inc., The Advisory Board Company - M&A Call

The Advisory Board Company Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 01:00 PM

The Advisory Board Company Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 01:00 PM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Michael T. Kirshbaum, Chief Financial Officer, Principal Accounting Officer and Treasurer.

The Advisory Board Company Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2014; Revises Earnings Guidance for the Year 2014; Provides Tax Rate Guidance for the Third Quarter of Fiscal 2015

The Advisory Board Company reported unaudited consolidated earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported statements of income revenue of $144,220,000 against $128,341,000 a year ago. Income before provision for income taxes and equity in loss of unconsolidated entities was $8,247,000 against $12,481,000 a year ago. Net income attributable to common stockholders was $6,490,000 against $9,002,000 a year ago. Basic and diluted net income attributable to common stockholders was $0.18 against $0.24 a year ago. Adjusted EBITDA was $25,402,000 against $22,306,000 a year ago. Adjusted net income was $15,852,000 against $11,385,000 a year ago. Non-GAAP earnings per diluted share were $0.43 against $0.31 a year ago. During the quarter ended September 30, 2014, the company reported cash flow provided by operating activities was $17.4 million compared to cash flow provided by operating activities of $39.2 million in the same quarter last year. Capital expenditures for the quarter ended September 30, 2014 were approximately $15.9 million compared to $14.2 million last September. For the six months, the company reported statements of income revenue of $286,040,000 against $251,557,000 a year ago. Income before provision for income taxes and equity in loss of unconsolidated entities was $18,193,000 against $23,742,000 a year ago. Net income attributable to common stockholders was $3,313,000 against $12,695,000 a year ago. Basic and diluted net income attributable to common stockholders was $0.09 against $0.35 a year ago. Adjusted EBITDA was $49,425,000 against $44,757,000 a year ago. Adjusted net income was $26,877,000 against $22,743,000 a year ago. Non-GAAP earnings per diluted share were $0.73 against $0.62 a year ago. Net cash flows provided by operating activities were $19,576,000 against $35,569,000 a year ago. Purchases of property and equipment were $26,634,000 against $23,585,000 a year ago. The company revised its previously announced calendar year 2014 guidance for revenue, adjusted EBITDA, and non-GAAP earnings per diluted share. For calendar year 2014, the company expects revenue to be in a range of approximately $570 million to $575 million, revised from $570 million to $580 million previously, adjusted EBITDA to be in a range of approximately $97 million to $100 million, revised from $97 million to $103 million previously, and non-GAAP earnings per diluted share to be in a range of approximately $1.27 to $1.32, revised from $1.14 to $1.25 previously. For calendar year 2014, the company expects amortization from acquisition-related intangible assets to be approximately $11 million. The company expects to return to a tax rate approximately 39% for the next quarter. For the next quarter tax rate is based on the assumption that the current R&D legislations expired.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABCO:US $47.27 USD -1.81

ABCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Evertz Technologies Ltd C$17.27 CAD +0.02
Grand Canyon Education Inc $46.56 USD +0.08
Huron Consulting Group Inc $69.34 USD 0.00
Korn/Ferry International $29.30 USD +0.14
MedAssets Inc $19.21 USD -0.04
View Industry Companies
 

Industry Analysis

ABCO

Industry Average

Valuation ABCO Industry Range
Price/Earnings 100.0x
Price/Sales 3.1x
Price/Book 5.4x
Price/Cash Flow 33.2x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVISORY BOARD CO/THE, please visit www.advisory.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.